Randal S. Weber

46.8k citations

405 papers · 28.7k indexed · 7 hit papers · h-index 78

Otorhinolaryngology top 0.01%
Surgery top 0.02%
Oncology top 0.05%
Pulmonary and Respiratory Medicine top 0.1%
Molecular Biology top 2%

Co-authors: David I. Rosenthal Adam S. Garden K. Kian Ang William H. Morrison Adel K. El‐Naggar Helmuth Goepfert Arlene A. Forastiere Jay S. Cooper
Topics: Head and Neck Cancer Studies (195 papers)Salivary Gland Tumors Diagnosis and Treatment (86 papers)Head and Neck Surgical Oncology (78 papers)
Cited by: Otorhinolaryngology Oncology Surgery
Journals: New England Journal of Medicine Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States Canada Italy

In The Last Decade

Randal S. Weber

396 papers receiving 28.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

2010 4.8k citations Jonathan Harris, Randal S. Weber et al. profile →
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

2003 2.3k citations Arlene A. Forastiere, Randal S. Weber et al. profile →
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

2008 1.0k citations Adam S. Garden, Randal S. Weber et al. Journal of Clinical Oncology profile →
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

2012 835 citations Arlene A. Forastiere, Randal S. Weber et al. Journal of Clinical Oncology profile →
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

2014 578 citations K. Kian Ang, David I. Rosenthal et al. Journal of Clinical Oncology profile →
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

2014 330 citations K. Kian Ang, Randal S. Weber et al. Journal of Clinical Oncology profile →
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy

2015 253 citations Randal S. Weber et al. Cancer profile →

Peers

Countries citing papers authored by Randal S. Weber

Since Specialization

Citations

This map shows the geographic impact of Randal S. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randal S. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randal S. Weber more than expected).

Fields of papers citing papers by Randal S. Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randal S. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randal S. Weber. The network helps show where Randal S. Weber may publish in the future.

Co-authorship network of co-authors of Randal S. Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Randal S. Weber. A scholar is included among the top collaborators of Randal S. Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randal S. Weber. Randal S. Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intestinal-Type Adenocarcinoma in Head and Neck: Dissecting Oncogenic Gene Alterations Through Whole Transcriptome and Exome Analysis 2023 ·Modern Pathology ·Diana Bell,Achim Bell,Randal S. Weber,Ehab Y. Hanna	0
2	Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes 2021 ·Cancer ·Kimberley L. Kiong,Christopher M. K. L. Yao,Fang‐Yu Lin,Diana Bell,Renata Ferrarotto,Randal S. Weber,Carol M. Lewis	4
3	The tumor immune contexture of salivary duct carcinoma 2021 ·Head & Neck ·Gustavo Schvartsman,Diana Bell,M. Laura Rubin,Michael T. Tetzlaff,Ehab Y. Hanna,J. Jack Lee,Randal S. Weber,Jack Phan,Bonnie S. Glisson,Renata Ferrarotto	10
4	Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer 2020 ·Cancer ·Kimberley L. Kiong,Fang‐Yu Lin,Christopher M. K. L. Yao,Theresa Guo,Renata Ferrarotto,Randal S. Weber,Carol M. Lewis	9
5	Association between postoperative complications and long‐term oncologic outcomes following total laryngectomy: 10‐year experience at MD Anderson Cancer Center 2020 ·Cancer ·Stefanos Boukovalas,Ryan P. Goepfert,Jeffrey M. Smith,(unknown),Jun Liu,Mark Zafereo,Edward I. Chang,Amy C. Hessel,Matthew M. Hanasono,Neil D. Gross,Peirong Yu,Jan S. Lewin,Carol M. Lewis,Eduardo M. Diaz,Randal S. Weber,Jeffrey N. Myers,Anaeze C. Offodile	13
6	Incompletely treated malignancies of the major salivary gland: Toward evidence‐based care 2018 ·Head & Neck ·Samantha Tam,Vlad C. Sandulache,(unknown),Crosby D. Rock,(unknown),Tommy Sheu,Adel K. El‐Naggar,Clifton D. Fuller,Randal S. Weber,Stephen Y. Lai	5
7	Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy 2018 ·Cancer ·Pierre Saintigny,Yoshitsugu Mitani,Kristen B. Pytynia,Renata Ferrarotto,Dianna Roberts,Randal S. Weber,Merrill S. Kies,Sankar N. Maity,Sue‐Hwa Lin,Adel K. El‐Naggar	24
8	Nontarget Swallowing Muscles Dose-Volume Correlates of Patient-Reported Outcomes After Oropharyngeal Intensity Modulated Radiation Therapy (IMRT) 2016 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),Abdallah Mohamed,G. Brandon Gunn,Katherine A. Hutcheson,(unknown),Adam S. Garden,(unknown),Jack Phan,William H. Morrison,Stephen Y. Lai,Beth M. Beadle,Randal S. Weber,M.S. Kies,David I. Rosenthal,Clifton D. Fuller	0
9	Complications, hospital length of stay, and readmission after total laryngectomy 2016 ·Cancer ·Ryan P. Goepfert,Katherine A. Hutcheson,Jan S. Lewin,(unknown),Mark Zafereo,Amy C. Hessel,Carol M. Lewis,Randal S. Weber,Neil D. Gross	71
10	Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations 2015 ·Clinical Cancer Research ·Yoshitsugu Mitani,Bin Liu,Pulivarthi H. Rao,Vishnupriya J. Borra,Mark Zafereo,Randal S. Weber,Merrill S. Kies,Guillermina Lozano,P. Andrew Futreal,Carlos Caulı́n,Adel K. El‐Naggar	154
11	Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications 2014 ·Clinical Cancer Research ·Yoshitsugu Mitani,Pulivarthi H. Rao,Sankar N. Maity,Yu-Chen Lee,Renata Ferrarotto,(unknown),Lisa Licitra,Scott M. Lippman,Merrill S. Kies,Randal S. Weber,Carlos Caulı́n,Sue-Hwa Lin,Adel K. El‐Naggar	56
12	A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck 2012 ·Clinical Cancer Research ·Carol M. Lewis,Bonnie S. Glisson,Lei Feng,Fiona Wan,Ximing Tang,Ignacio I. Wistuba,Adel K. El‐Naggar,David I. Rosenthal,Mark S. Chambers,Robert A. Lustig,Randal S. Weber	131
13	DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy 2011 ·Clinical Cancer Research ·Benjamin J. Moeller,John S. Yordy,Michelle D. Williams,Uma Giri,Uma Raju,David Molkentine,Lauren A. Byers,John V. Heymach,Michael D. Story,J. Jack Lee,Erich M. Sturgis,Randal S. Weber,Adam S. Garden,(unknown),David A. Schwartz	75
14	Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB – NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome 2011 ·Clinical Cancer Research ·Yoshitsugu Mitani,Pulivarthi H. Rao,P. Andrew Futreal,Dianna Roberts,Philip J. Stephens,Yi-Jue Zhao,Li Zhang,(unknown),Randal S. Weber,Scott M. Lippman,Carlos Caulı́n,Adel K. El‐Naggar	116
15	Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance 2010 ·Clinical Cancer Research ·Yoshitsugu Mitani,Jie Li,Pulivarthi H. Rao,Yi-Jue Zhao,Diana Bell,Scott M. Lippman,Randal S. Weber,Carlos Caulı́n,Adel K. El‐Naggar	219
16	Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance 2010 ·Clinical Cancer Research ·Michelle D. Williams,Dianna Roberts,Merrill S. Kies,Li Mao,Randal S. Weber,Adel K. El‐Naggar	99
17	Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024 2009 ·Journal of Clinical Oncology ·David I. Rosenthal,Jonathan Harris,Arlene A. Forastiere,Randal S. Weber,John A. Ridge,Jeffrey N. Myers,Adam S. Garden,Michael Kuettel,(unknown),Christopher J. Schultz,Andy Trotti,K. Kian Ang	32
18	Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Update of a Phase II Trial of the RTOG (99-14) 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Adam S. Garden,Jonathan Harris,(unknown),A. Trotti,(unknown),J. Cheng,Sharon A. Spencer,Randal S. Weber,K. Kian Ang	2
19	Early postoperative paclitaxel followed by paclitaxel and cisplatin concurrent with radiation therapy (RT) (phase II trial RTOG H-0024) is well tolerated for patients with resected, high-risk squamous carcinoma of the head and neck (HNSCC) 2004 ·International Journal of Radiation OncologyBiologyPhysics ·David I. Rosenthal,Jay R. Harris,Arlene A. Forastiere,Randal S. Weber,John A. Ridge,Jeffrey N. Myers,Adam S. Garden,Michael Kuettel,(unknown),Christopher J. Schultz,K. Kian Ang	2
20	Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Matthew T. Ballo,Gunar K. Zagars,(unknown),(unknown),(unknown),Erich M. Sturgis,Jeffrey E. Gershenwald,Merrick I. Ross,Randal S. Weber	2

About Randal S. Weber

Randal S. Weber is a scholar working on Otorhinolaryngology, Oncology and Surgery, having authored 405 papers that have together received 28.7k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (195 papers), Salivary Gland Tumors Diagnosis and Treatment (86 papers) and Head and Neck Surgical Oncology (78 papers). The work is most often cited by research in Otorhinolaryngology (16.1k citations), Oncology (10.1k citations) and Surgery (14.8k citations). Randal S. Weber has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include David I. Rosenthal, Adam S. Garden, K. Kian Ang, William H. Morrison, Adel K. El‐Naggar, Helmuth Goepfert, Arlene A. Forastiere, Jay S. Cooper, Jonathan Harris and Phuc Félix Nguyen‐Tan. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact